ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,058.47
0.18%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sinovac Biotech Ltd (SVA)

  7. Sinovac Biotech Ltd (SVA) News

Sinovac Biotech (SVA)

Sinovac Biotech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SVA
DateTimeSourceHeadlineSymbolCompany
29/04/202422:53Business WireSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FNASDAQ:SVASinovac Biotech Ltd
21/02/202411:09Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:SVASinovac Biotech Ltd
21/02/202411:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
21/02/202407:56Business WireSinovac Amends Shareholder Rights PlanNASDAQ:SVASinovac Biotech Ltd
02/02/202416:19Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
19/01/202411:58Business Wireシノバック取締役会、一方的な部分公開買い付けを全会一致で退けるNASDAQ:SVASinovac Biotech Ltd
18/01/202419:54Business WireSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案NASDAQ:SVASinovac Biotech Ltd
18/01/202419:47Business WireLe conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
18/01/202418:33Business WireDas Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot abNASDAQ:SVASinovac Biotech Ltd
18/01/202412:13Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
18/01/202412:00Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
08/01/202421:46Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SVASinovac Biotech Ltd
04/12/202311:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
03/10/202314:39Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
15/09/202313:59Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
12/09/202311:10Business Wireシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告NASDAQ:SVASinovac Biotech Ltd
11/09/202315:36Business WireSINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55NASDAQ:SVASinovac Biotech Ltd
11/09/202315:36Business WireSINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
11/09/202311:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
11/09/202310:55Business WireSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
06/09/202312:35Business Wireシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否NASDAQ:SVASinovac Biotech Ltd
05/09/202317:16Business WireSinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig abNASDAQ:SVASinovac Biotech Ltd
05/09/202316:36Business WireLe conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
05/09/202312:04Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
05/09/202309:12Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
29/08/202318:08Business Wireシノバック、部分的な株式公開買付を一方的に受けたことを確認NASDAQ:SVASinovac Biotech Ltd
29/08/202314:04Business WireSinovac bestätigt den Erhalt eines unangeforderten TeilübernahmeangebotsNASDAQ:SVASinovac Biotech Ltd
29/08/202311:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
29/08/202311:05Business WireSinovac confirme la réception d'une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202308:07Business WireSinovac Confirms Receipt of an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:SVA

Your Recent History

LSE
BTSM
BSS Group
LSE
SGEA
Ishr Em A L G B
LSE
RWA
Robert Walters
LSE
FOR
LSE
FFU
LSE
JHD
James Halstead
TG
CSV
Corporacion Financiera A...
LSE
0MWL
Vaneck Vectors Ucits Etfs
LSE
TRP
Tower Resources
LSE
MWJ
Morant Wright Japan Income Trust
LSE
WET
Watermark Global
EU
ALLOG
Logic Instrument
NYSE
VIST
Vista Energy SAB de CV
LSE
AINC
LSE
ATIA
LSE
AEL
Anzon Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved